About Newcardio (OTCMKTS:NWCI)
NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey.
Industry, Sector and Symbol
Industry Electromedical equipment
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Newcardio (OTCMKTS:NWCI) Frequently Asked Questions
What is Newcardio's stock symbol?
Newcardio trades on the OTCMKTS under the ticker symbol "NWCI."
Who are some of Newcardio's key competitors?
Some companies that are related to Newcardio include Medtronic (MDT), Varian Medical Systems (VAR), Sonova (SONVY), Masimo (MASI), LivaNova (LIVN), Getinge Group (GNGBY), CONMED (CNMD), NxStage (NXTM), AxoGen (AXGN), Natus Medical (BABY), Cutera (CUTR), Viewray (VRAY), Rockwell Medical (RMTI), Vision Sciences (CGNT) and Fonar (FONR).
Who are Newcardio's key executives?
Newcardio's management team includes the folowing people:
- Dr. Jess Emery Jones M.D., Chief Exec. Officer and Director (Age 39)
- Dr. Ihor Gussak M.D., Ph.D., FACC, Chief Medical Officer and VP
- Mr. Greg Sadowski, Chief Operating Officer
- Mr. Gilbert V. Molina, Director of Corp. Systems
- Dr. Gari Clifford Ph.D., Technology Advisor
Has Newcardio been receiving favorable news coverage?
Media stories about NWCI stock have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern scores the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Newcardio earned a news impact score of 0.14 on Accern's scale. They also gave media headlines about the company an impact score of 45.28 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
How do I buy shares of Newcardio?
Shares of NWCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Newcardio's stock price today?
One share of NWCI stock can currently be purchased for approximately $0.0016.
How big of a company is Newcardio?
Newcardio has a market capitalization of $70,000.00.
How can I contact Newcardio?
Newcardio's mailing address is 2350 MISSION COLLEGE BLVD. #1175, SANTA CLARA CA, 95054. The company can be reached via phone at 510-774-1969 or via email at [email protected]
MarketBeat Community Rating for Newcardio (NWCI)MarketBeat's community ratings are surveys of what our community members think about Newcardio and other stocks. Vote "Outperform" if you believe NWCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NWCI will underperform the S&P 500 over the long term. You may vote once every thirty days.
Newcardio (OTCMKTS:NWCI) Analyst Ratings History
(Data available from 4/24/2016 forward)
Newcardio (OTCMKTS:NWCI) Earnings History and Estimates Chart
Newcardio (OTCMKTS NWCI) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Newcardio (OTCMKTS:NWCI) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Newcardio (OTCMKTS NWCI) Insider Trading and Institutional Ownership History
Newcardio (OTCMKTS NWCI) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Newcardio (OTCMKTS NWCI) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Newcardio (OTCMKTS:NWCI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Newcardio (OTCMKTS NWCI) Stock Chart for Tuesday, April, 24, 2018